Haemostasis and pregnancy;Hémostase et grossesse

EMC - Hematologie

Volumn 2, Issue 2, 2005, Pages 132-143

  Boyer Neumann, C ^a  

^a HÔPITAL ANTOINE BÉCLÈRE   (France)

Author keywords

Anticoagulant treatment; Bleeding; Haemostasis; Inflammation; Pregnancy; Thrombosis

Indexed keywords

EID: 32644444124     PISSN: 16386213     EISSN: 16386213     Source Type: Journal    
DOI: 10.1016/j.emch.2005.01.001     Document Type: Short Survey

References (67)

1. Stirling Y, Woolf L, North WR, Segatchian MJ, Meade TW. Haemostasis in normal pregnancy. Thromb Haemost 1984;52:176-82.
2. Bonnar J. Haemostasis and coagulation disorders in pregnancy. In: Bloom AL, Thomas DP, editors. Haemostasis and thrombosis, Edinburgh: Churchill Livingstone; 1987. p. 570-84.
3. Gerbasi FR, Bottoms S, Farag A, Mammen E. Increased intravascular coagulation, associated with pregnancy. Obstet Gynecol 1990;75:385-9.
4. Caldwell DC, Williamson RA, Goldsmith JC. Hereditary coagulopathies in pregnancy. Haematological disorders in pregnancy. Clin Obstet Gynecol 1985;28:53-72.
5. . Sainio S, Kekomäki R, Riikonen S, Teramo K. Maternal thrombocytopenia at term: a population-based study. Acta Obstet Gynaecol Scand 2000;79:744-9.
6. Burrows RF. Platelets disorders in pregnancy. Curr Opin Obstet Gynecol 2001;13:115-9.
7. Wallenburg HC, Kessel PH. Platelets lifespan in normal pregnancy as determined by a non-radio-isotopic technique. Br J Obstet Gynaecol 1978;85:33-6.
8. Fay RA, Hughes AO, Farron NT. Platelets in pregnancy: hyperdestruction in pregnancy. Obstet Gynecol 1983;61:238-40.
9. Fitzgerald DJ, Mayo G, Catella F, Entman SS., Fitzgerald GA. Increased thromboxane biosynthesis in normal pregnancy is mainly derived from platelets. Am J Obstet Gynecol 1987;157:325-30.
10. Bremme KA. Haemostatic changes in pregnancy. Best Pract Res Clin Haematol 2003;16:153-68.
11. Dreyfus M, Veyradier A, Lambert T, Blot I, Tchernia G. Hématologie et grossesse. In: Traité d'obstétrique. Paris: Médecine-Sciences Flammarion; 2003. p. 617-34.
12. Hellgren M, Blomback M. Studies on blood coagulation and fibrinolysis in pregnancy during delivery and in the puerperium. Gynecol Obstet Invest 1981;12:141-54.
13. Asakura H, Ohshita T, Suzuki S, Araki T. Correlation between grade III placenta and plasma antithrombin III activity in full term pregnancy. Gynecol Obstet Invest 2001;52:417-50.
14. Faught W, Garner P, Jones G, Ivey B. Changes in protein C and protein S levels in normal pregnancy. Am J Obstet Gynecol 1995;172:147-50.
15. 4b-binding protein during pregnancy and oral contraception. Br J Haematot 1988;68:437-43.
16. Fernandez JA, Estelles A, Gilabert J, Espana F, Aznar J. Functional and immunologic protein S in normal pregnant women and in full-term newborns. Thromb Haemost 1989;61:474-8.
17. Kjellberg U, Andersson NE, Rosén S, Tengborn L, Hellgren M. APC resistance and other haemostatic variables during pregnancy and puerperium. Thromb Haemost 1999;81:527-31.
18. Clarck P, Brennand J, Conkie JA, McCalle F, Greer IA, Walker ID. Activated protein C sensitivity. Protein C, protein S and coagulation in normal pregnancy. Thromb Haemost 1998;79:1166-70.
19. Giavarina D, Mezzana G, Dorizzi RM, Soffiati G. Reference interval of D-dimer in pregnant women. Clin Biochem 2001;34:331-3.
20. De Boer K, Ten Cate JW, Sturk A, Borm JJ, Treffers PE. Enhanced thrombin generation in normal and hypertensive pregnancy. Am J Obstet Gynecol 1989;160:95-107.
21. Sarig S, Brenner B. Coagulation, inflammation, and pregnancy complications. Lancet 2004;363:96-7.
22. Kobayashi T, Terao T, Maki M, Ikenoue T. Diagnosis and management of acute DIG. Semin Thromb Hemost 2001;27:161-7.
23. Weiner CP. Thrombotic microangiopathy in pregnancy and in the postpartum period. Semin Hematol 1987;34:148-58.
24. Haddad T. Update on pre-eclampsia. Int Anesthesiol Clin 2002;40:115-35.
25. Roberts JM, Lain KY. Recents insights into the pathogenesis of the pre-eclampsia. Placenta 2002;23:359-73.
26. Weinstein L. Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy. Am J Obstet Gynecol 1982;142:159-67.
27. Tsai MM. Advances in the pathogenesis, diagnosis and treatment of thrombotic trombocytopenic purpura. J Am Soc Nephrol 2003;14:1072-81.
28. Proia A, Paesano R, Torcia F, Annino L, Capria S, Ferrari A, et al. Thrombotic thrombocytopenic purpura and pregnancy: a case report and a review of the literature. Ann Hematol 2002;81:210-4.
29. Coppo P, Veyradier A, Durey MA, Fremeaux-Bacchi V, Scrobohaci ML, Amesland F, et al. Physiopathologie des microangiopathies thrombotiques. Ann Med Interne (Paris) 2001;153:153-66.
30. Lattuada A, Rossi E, Calzarossa C, Gandolfi R, Mannucci PM. Mild to moderate reduction of a von Willebrand factor cleaving protease (ADAMTS-13) in pregnant women with HELLP microangiopathic syndrome. Haematologica 2003;88:1029-34.
31. Noller KL, Bowle EJ, Kempers RD, Owen CA. Von willebrand's disease in pregnancy. Obstet Gynecol 1973;41:865-72.
32. Sanchez-Luceros A, Meschengieser SS, Marchese C, Votta R, Casais P, Woods AI, et al. Factor VIII and von Willebrand factor changes during normal pregnancy and puerperium. Blood Coag Fibrinol 2003;14:647-51.
33. Sonosky J, Klatsky A, Norbert GF, Burchelle RC. Von Willebrand's disease complicating second-trimester abortion. Obstet Gynecol 1980;55:253-4.
34. Chediak JR, Alaban GM, Maxey B. Von Willebrand's disease and pregnancy: management during delivery and outcome of offspring. Am J Obstet Gynecol 1986;155:618-24.
35. Boyer-Neumann C, Dreyfus M, Wolf M, Veyradier A, Meyer D. Multi-therapeutic approach to manage delivery in a alloimmunized patient with type 3 von Willebrand disease. Thromb Haemost 2003;1:190-2.
36. Kashyap R, Kriplani A, Saxena R, Takkar D, Choudhry VP. Pregnancy in a patient of Glanzmann's thrombasthenia with antiplatelet antibodies. J Obstet Gynecol Res 1997;23:247-50.
37. Sherer DM, Lerner R. Glanzmann's thrombasthenia in pregnancy: a case and review of the literature. Am J Perinatol 1999;16:297-301.
38. Monrigal C, Beurrier P, Mercier FJ, Boyer-Neumann C, Gillard P. Glanzmann's thrombasthenia and pregnancy: a case and review of the literature. Ann Fr Anesth Reanim 2003;22:826-30.
39. D'Oiron R, Menart C, Trzeciak MC, Nurden P, Fressinaud E, Dreyfus M, et al. Use of recombinant factor Vila in 3 patients with inherited type I Glanzmann's thrombasthenia undergoing invasive procedures. Thromb Haemost 2000;83:637-8.
40. Letsky EA, Greaves M. Guidelines on the investigation and management of thrombocytopenia in pregnancy and neonatal alloimmune thrombocytopenia. Br J Obstet Gynaecol 1997;104:1108.
41. Ajzenberg N, Dreyfus M, Kaplan C, Yvart J, Weill B, Tchernia G. Pregnancy-associated thrombocytopenia revisited: assessment and follow-up of 50 cases. Blood 1998;92:4573-80.
42. British Committee for Standards in Haematology General Task Force. Guidelines for the investigation and management of idiopathic thrombocytopenia in adults, children and in pregnancy. Br J Haematol 2003;120:574-96.
43. Murray JM, Harris RE. The management of the pregnant patient with idiopathic thrombocytopenic purpura. Am J Obstet Gynecol 1976;126:449-51.
44. Bussel JB, Druzin ML, Cines DB, Samuels P. Thrombocytopenia in pregnancy. Lancet 1991;337:251.
45. Burrows RF, Kelton JC. Fetal thrombocytopenia and its relation to maternal thrombocytopenia. N Engl J Med 1993;329:1463-6.
46. Boyer-Neumann C. Immunologie de la thrombopénie néonatale. Med Clin Pediatr 2002;2:66-8.
47. Howland EJ, Palmer J, Lumley M, Keay SD. Acquired factor VIII inhibitors as a cause of primary post-partum haemorrhage. Eur J Obstet Gynecol Reprod Biol 2002;103:97-8.
48. Collins PW. Management of acquired haemophilia: A more questions than answers. Blood Coagul Fibrinolysis 2003;14:23-7.
49. Toglia MR, Weg JG. Venous thromboembolism during pregnancy. N Engl J Med 1996;335:543-52.
50. Tsai AW, Cushman M, Tsai MY, Heckbert SR, Rosamond WD, Aleksic N, et al. Serum homocysteine thermolabile variant of methylene tetrahydrofolate reductase (MTHFR) and venous thromboembolism: Longitudinal Investigation of Thromboembolism Etiology (LITE). Am J Hematol 2003;72:192-200.
51. Walker ID. Thrombophilia in pregnancy. J Clin Pathol 2000;53:573-80.
52. McColl MD, Ramsay JE, Tait RC, Walker ID, McColl F, Conkie JA, et al. Risk factors for pregnancy associated venous thromboembolism. Thromb Haemost 1997;78:1183-8.
53. De Stefano V, Leone G, Masterangelo S, Tripodi A, Rodeghiero F, Castaman G, et al. Thrombosis during pregnancy and surgery in patients with congenital deficiency of antithrombin III, protein C-protein S. Thromb Haemost 1994;71:799-800.
54. Pabinger I and the study group on Natural Inhibitors. Thrombotic risk in hereditary antithrombin III, protein C and protein S deficiency. Arterioscler Thromb Vasc Biol 1996;16:747-8.
55. Conard J, Horellou MH, van Dreden P. Thrombosis and pregnancy in congenital deficiencies of antithrombin III, protein C or protein S: study of 78 women. Thromb Haemost 1990;63:319-20.
56. Grandone E, Margaglione M, Colaizzo D. Genetic susceptibility to pregnancy-related venous thromboembolism: roles of factor V Leiden, protrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations. Am J Obstet Gynecol 1998;179:1324-8.
57. Gerhart A, Scharf RE, Beckmann MW, Struve S, Bender HG, Pillny M, et al. Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperum. N Engl J Med 2000;342:374-80.
58. Mc Coll MD, Ellison J, Reid F, Tait RC, Walker ID, Greer I. Prothrombin 20210 G A, MTHFR C677T mutations in women with venous thromboembolism associated with pregnancy. Br J Obst Gynaecol 2000;107:565-9.
59. Martinelli I, De Stefano V, Taioli E, Paciaroni K, Rossi E, Mannucci PM. Inherited thrombophilia and first venous thrombembolism during pregnancy and puerperium, Thromb Haemost 2002;87:791-5.
60. De Stefano V, Rossi E, Leone G. Inherited thrombophilia, pregnancy and oral contraceptive use: clinical implications. Semin Vasc Med 2002;3:47-59.
61. Greer IA. Thrombosis in pregnancy: maternal and fetal issues. Lancet 1999;353:1258-65.
62. Kupferminc MJ, Rimon E, Asher-Landsberg J, Lessing JB, Many A. Perinatal outcome in women with severe pregnancy complications and multiple thrombophilias. J Pehnat Med 2004;32:225-7.
63. Brenner B, Huffman R, Blumenfeld Z, Weiner Z, Younis JS. Gestational outcome in thrombophilic women with recurrent pregnancy loss treated by enoxaparin. Thromb Haemost 2000;83:693-7.
64. Sanson BJ, Lensing AWA, Prins MH, Ginsberg JS, Barkagan ZS, Lavenne-Pardonge E, et al. Safety of low-molecular-weight heparin in pregnancy: a systemic review. Thromb Haemost 1999;81:668-72.
65. Bates SM, Ginsberg JS. How we manage venous thromboembolism during pregnancy. Blood 2002;100(10):3470-8.
66. Greer IA. Prevention of thromboembolism in pregnancy. Eur J Med Res 2004;30:135-45.
67. Chan WS, Anand S, Ginsberg JS. Anticoagulation of pregnant women with mechanical heart valves: a systemic review of the literature. Arch Intern Med 2000;160:191-6.